Warnex Inc.  

(Public, TSE:WNX)   Watch this stock  
Find more results for tse:wnx
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 0.01 - 0.08
Open     -
Vol / Avg. 0.00/85,563.00
Mkt cap 3.40M
P/E     -
Div/yield     -
EPS -0.01
Shares     -
Beta 1.24
Inst. own     -

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -14.15% -48.03%
Return on average equity -15.01% -53.23%
Employees 250 -
CDP Score - -


Suite 200, 1375 TransCanada Highway
+1-450-6636724 (Phone)
+1-450-6692784 (Fax)


Warnex Inc. is a life sciences company engaged in providing diverse laboratory services. The Company offers analytical services to the pharmaceutical sector. Its analytical Services provide quality control services to the pharmaceutical and biotechnology industries, including chemistry, chromatography, microbiology, method development and validation, and stability studies. The Company sold the assets of its Medical Laboratories division to Gamma-Dynacare Medical Laboratories. It sold its Analytical Services division to NEOPHARM LABS Inc. The Company sold its Bioanalytical Services division to Biotrial Research S.A.S. In July 2014, Diagnos Inc announced the completion of the merger of Warnex Inc. with the wholly owned subsidiary of Diagnos Inc.

Officers and directors

Michael Singer Independent Chairman of the Board
Age: 48
Sean Karamchandani Interim Chief Executive Officer, Chief Financial Officer, Director
Joseph A. Walewicz Independent Director